Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update

Journal of Clinical Pharmacology

Volumn 56, Issue 2, 2016, Pages 170-175

  Chitayat, David ^a,b   Matsui, Doreen ^c   Amitai, Yona ^d   Kennedy, Deborah ^e   Vohra, Sunita ^f   Rieder, Michael ^c   Koren, Gideon ^g  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d BAR ILAN UNIVERSITY   (Israel)

^e University of Alberta ^*  (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

folate; folic acid; genetics of neural tube defects; neural tube defects; prevention; spina bifida

Indexed keywords

FOLIC ACID; VITAMIN;

CHINA; COCHRANE LIBRARY; EMBASE; GENETIC VARIABILITY; HUMAN; MEDLINE; NEURAL TUBE DEFECT; PRACTICE GUIDELINE; PREGNANCY; REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW; UNITED STATES; WEB OF SCIENCE; ANENCEPHALY; DIETARY SUPPLEMENT; DOSE RESPONSE; FEMALE;

ANENCEPHALY; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; HUMANS; PREGNANCY; VITAMINS;

EID: 84956756059     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.616     Document Type: Review

References (44)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991; 338 (8760): 131-137.
2. Czeizel AE, Dudás I,. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992; 327 (26): 1832-1835.
3. Werler MM, Louik C, Mitchell AA,. Achieving a public health recommendation for preventing neural tube defects with folic acid. Am J Public Health. 1999; 89 (11): 1637-1640.
4. Williams J, Mai CT, Mulinare J, et al., Updated estimates of neural tube defects prevented by mandatory folic acid fortification-United States, 1995-2011. MMWR Morbid Mortal Wkly Rep. 2015; 64 (1): 1-5.
5. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM,. Folate levels and neural tube defects. Implications for prevention. JAMA 1995; 274 (21): 1698-1702.
6. Crider KS, Devine O, Hao L, et al., Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 2014; 349: g4554. doi: 10.1136/bmj.g4554
7. Wald NJ, Law MR, Morris JK, Wald DS., Quantifying the effect of folic acid. Lancet. 2001; 358 (9298): 2069-2073.
8. Bar-Oz B, Koren G, Nguyen P, Kapur BM., Folate fortification and supplementation-are we there yet ? Reprod Toxicol. 2008; 25 (4): 408-412.
9. Bradbury KE, Williams SM, Green TJ, et al., Differences in erythrocyte folate concentrations in older adults reached steady-state within one year in a two-year, controlled, 1 mg/d folate supplementation trial. J Nutr. 2012; 142 (9): 1633-1637.
10. Yang Q, Cogswell ME, Hamner HC, et al., Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr. 2010; 91 (1): 64-72.
11. Nguyen P, Boskovic R, Yazdani P, Kapur B, Vandenberghe H, Koren G., Comparing folic acid pharmacokinetics among women of childbearing age: single dose ingestion of 1.1 versus 5 mg folic acid. Can J Clin Pharmacol. 2008; 15 (2): e314-e322.
12. Hancock R, Koren G., Celiac disease during pregnancy. Can Fam Physician. 2004; 50: 1361-1363.
13. Nguyen P, Thomas M, Koren G., Predictors of prenatal multivitamin adherence in pregnant women. J Clin Pharmacol. 2009; 49 (6): 735-742.
14. de Benoist B., Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull. 2008; 29 (2 Suppl): S238-S244.
15. Shere M, Bapat P, NickeL C, Kapur B, Koren G., Association between folate status and use of oral contraceptives: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2015; 37 (5): 430-438.
16. Steger GG, Mader RM, Vogelsang H, Schöfl R, Lochs H, Ferenci P., Folate absorption in Crohn's disease. Digestion. 1994; 55 (4): 234-238.
17. Crider KS, Zhu JH, Hao L, et al., MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr. 2011; 93 (6): 1365-1372.
18. Rothenberg SP, da Costa MP, Sequeira JM, et al., Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 2004; 350 (2): 134-142.
19. Pei L, Liu J, Zhang Y, Zhu H, Ren A., Association of reduced folate carrier gene polymorphism and maternal folic acid use with neural tube defects. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B (6): 874-878.
20. Bailey LB., Folate in Health and Disease. 2nd ed. Boca Raton: Taylor & Francis; 2010.
21. De Marco P, Calevo MG, Moroni A, et al., Reduced folate carrier polymorphism (80A→G) and neural tube defects. Eur J Hum Genet. 2003; 11 (3): 245-252.
22. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH., Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet. 2002; 108 (1): 1-6.
23. De Marco P, Merello E, Calevo MG, et al., Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G> A polymorphism for neural tube defect risk. J Hum Genet. 2006; 51 (2): 98-103.
24. Johnson WG, Stenroos ES, Spychala JR, et al., New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy ? Am J Med Genet A. 2004; 124A (4): 339-345.
25. Botto LD, Yang Q,. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000; 151 (9): 862-877.
26. De Marco P, Calevo MG, Moroni A, et al., Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet. 2002; 47 (6): 319-324.
27. Volcik KA, Shaw GM, Zhu H, Lammer EJ, Laurent C, Finnell RH., Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol. 2003; 67 (11): 924-928.
28. Matok I, Gorodischer R, Koren G, Landau D, Wiznitzer A, Levy A., Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. Br J Clin Pharmacol. 2009; 68 (6): 956-961.
29. Roy M, Leclerc D, Wu Q, Gupta S, Kruger WD, Rozen R., Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency. J Cell Biochem. 2008; 105 (2): 467-476.
30. Umur AS, Selcuki M, Bursali A, et al., Simultaneous folate intake may prevent adverse effect of valproic acid on neurulating nervous system. Childs Nerv Syst. 2012; 28 (5): 729-737.
31. Tomson T, Battino D, Bonizzoni E, et al., Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011; 10 (7): 609-617.
32. Gao LJ, Wang ZP, Lu QB, Gong R, Sun XH, Zhao ZT., Maternal overweight and obesity and the risk of neural tube defects: a case-control study in China. Birth Defects Res A Clin Mol Teratol. 2013; 97 (3): 161-165.
33. Wang M, Wang ZP, Zhang M, Zhao ZT., Maternal passive smoking during pregnancy and neural tube defects in offspring: a meta-analysis. Arch Gynecol Obstet. 2014; 289 (3): 513-521.
34. Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM., The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol. 2013; 209 (3): 239.e1-8.
35. Valera-Gran D, García de la Hera M, Navarrete-Muñoz EM,. Infancia y Medio Ambiente (INMA) Project. Folic acid supplements during pregnancy and child psychomotor development after the first year of life. JAMA Pediatr. 2014; 168 (11): e142611. doi: 10.1001/jamapediatrics.2014.2611.
36. Kennedy DA, Stern SJ, Moretti M., Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011; 35 (1): 2-10.
37. Kim DH, Smith-Warner SA, Spiegelman D, et al., Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control. 2010; 21 (11): 1919-1930.
38. Fife J, Raniga S, Hider PN, Frizelle FA., Folic acid supplementation and colorectal cancer risk: a meta-analysis. Colorectal Dis. 2011; 13 (2): 132-137.
39. Shere M, Nguyen P, Tam C, et al., Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: a randomized clinical trial. J Clin Pharmacol. 2014. doi: 10.1002/jcph.387.
40. Nguyen P, Tam C, O'Connor DL, Kapur B, Koren G., Steady state folate concentrations achieved with 5 mg compared with 1.1 mg folic acid supplementation among women of childbearing age. Am J Clin Nutr. 2009; 89: 844-852.
41. Ly A, Hoyt L, Crowell J, Kim YI., Folate and DNA methylation. Antioxid Redox Signal. 2012; 17 (2): 302-326.
42. Yang L, Jiang L, Bi M, et al., High dose of maternal folic acid supplementation is associated to infant asthma. Food Chem Toxicol. 2015; 75: 88-93.
43. Zetstra-van der Woude PA, De Walle HE, Hoek A, et al., Maternal high-dose folic acid during pregnancy and asthma medication in the offspring. Pharmacoepidemiol Drug Saf. 2014; 23 (10): 1059-1065.
44. FIGO Working Group on Best Practice in Maternal-Fetal Medicine. Best practices in maternal fetal medicine. Int J Gynecol Obstet. 2015; 128: 80-82.